Results 21 to 30 of about 17,151,553 (293)
Bile acids are metabolites involved in nutrient absorption and signaling with levels influenced by dietary intake, metabolic processes, and the gut microbiome.
Shanalee C. James +9 more
doaj +1 more source
Fecal microbiota transplantation (FMT) is an attractive strategy to correct microbial dysbiosis in diarrhea-predominant irritable bowel syndrome (IBS-D).
John M. Kelley +17 more
core +1 more source
Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical ...
Cristina Pardo-Camacho +19 more
doaj +1 more source
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis, which affects approximately 4% of the global population. The Rome IV criteria define IBS as chronic or recurrent abdominal pain associated with altered bowel habits.
Esther Colomier +5 more
doaj +1 more source
Changes in intestinal microbiota have been linked to the development of diarrhea predominant irritable bowel syndrome (IBS-D). In order to better elucidate the relationship between intestinal microbiota changes and IBS-D, we compared fecal microbiota of ...
Fang Yang +6 more
doaj +1 more source
Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: Phase I-II clinical trial. [PDF]
Background and Aim Diet is a major contributor to irritable bowel syndrome (IBS) and is also a powerful tool for treatment of IBS. This study compared two diets and explored the effectiveness of the diets when combined with a probiotic for treatment of ...
Zhao XS +7 more
europepmc +2 more sources
Evaluation of prakṛti and quality-of-life in patients with irritable bowel syndrome
Objective: To evaluate the prakṛti of irritable bowel syndrome (IBS) patients and its association with IBS subtypes and quality-of-life (QOL). Methodology: IBS patients with the consistent subtype in the last 6 months were recruited.
Sudatta G Shirolkar +2 more
doaj +1 more source
Tong-Xie-Yao-Fang (TXYF) has been widely used for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) in traditional Chinese medicine. However, its mechanism of action in the treatment of IBS-D remains to be fully understood.
Junchen Li +9 more
doaj +1 more source
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Objective Gut microbiota might play a crucial role in the pathogenesis of irritable bowel syndrome (IBS), and probiotics supplement may be an effective treatment option.
Mei Luo +3 more
doaj +1 more source
The Value of PHQ-9 and GAD-7 for Screening Emotional Disorders in IBS-D and the Specificity of the Gut Flora Associated with Emotional Comorbidity: Preliminary Findings. [PDF]
Jun Zhao,1,2,* Xia Li,3,* Xin Wang,4 Xuefei Wang,4 Xin Hao,2 Zhigang Li,2 Lin Zhu1 1Department of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610044, People’s Republic of China; 2School of ...
Zhao J +6 more
europepmc +2 more sources

